Targeting of Interferon-Beta to Produce a Specific, Multi-Mechanistic Oncolytic Vaccinia Virus

• David H Kirn,

  Affiliations Jennerex Biotherapeutics, San Francisco, California, United States of America , Clinical Pharmacology, University of Oxford, Oxford, United Kingdom

  ⨯
• Yaohe Wang,

  Affiliation Cancer Research UK Molecular Oncology Centre, Queen Mary's School of Medicine and Dentistry, Charterhouse Square, London, United Kingdom

  ⨯
• Fabrice Le Boeuf,

  Affiliation Ottawa Health Research Institute, Ottawa, Ontario, Canada

  ⨯
• John Bell,

  Affiliation Ottawa Health Research Institute, Ottawa, Ontario, Canada

  ⨯
• Steve H Thorne

  *To whom correspondence should be addressed. E-mail: thornesh@upmc.edu

  ¤ Current address: Division of Surgical Oncology, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America

  Affiliations Jennerex Biotherapeutics, San Francisco, California, United States of America , Department of Pediatrics and Bio-X Program, Stanford University, Stanford, California, United States of America

  ⨯